Cargando…
Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695567/ https://www.ncbi.nlm.nih.gov/pubmed/33308937 http://dx.doi.org/10.1016/j.mehy.2020.110439 |
_version_ | 1783615217071030272 |
---|---|
author | Goren, Andy Cadegiani, Flavio Adsuara Wambier, Carlos Gustavo Vano-Galvan, Sergio Tosti, Antonella Shapiro, Jerry Mesinkovska, Natasha Atanaskova Ramos, Paulo Müller Sinclair, Rodney Lupi, Omar Hercogova, Jana McCoy, John |
author_facet | Goren, Andy Cadegiani, Flavio Adsuara Wambier, Carlos Gustavo Vano-Galvan, Sergio Tosti, Antonella Shapiro, Jerry Mesinkovska, Natasha Atanaskova Ramos, Paulo Müller Sinclair, Rodney Lupi, Omar Hercogova, Jana McCoy, John |
author_sort | Goren, Andy |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7695567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-76955672020-12-01 Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster Goren, Andy Cadegiani, Flavio Adsuara Wambier, Carlos Gustavo Vano-Galvan, Sergio Tosti, Antonella Shapiro, Jerry Mesinkovska, Natasha Atanaskova Ramos, Paulo Müller Sinclair, Rodney Lupi, Omar Hercogova, Jana McCoy, John Med Hypotheses Article Elsevier Ltd. 2021-01 2020-11-28 /pmc/articles/PMC7695567/ /pubmed/33308937 http://dx.doi.org/10.1016/j.mehy.2020.110439 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Goren, Andy Cadegiani, Flavio Adsuara Wambier, Carlos Gustavo Vano-Galvan, Sergio Tosti, Antonella Shapiro, Jerry Mesinkovska, Natasha Atanaskova Ramos, Paulo Müller Sinclair, Rodney Lupi, Omar Hercogova, Jana McCoy, John Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
title | Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
title_full | Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
title_fullStr | Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
title_full_unstemmed | Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
title_short | Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster |
title_sort | androgenetic alopecia may be associated with weaker covid-19 t-cell immune response: an insight into a potential covid-19 vaccine booster |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695567/ https://www.ncbi.nlm.nih.gov/pubmed/33308937 http://dx.doi.org/10.1016/j.mehy.2020.110439 |
work_keys_str_mv | AT gorenandy androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT cadegianiflavioadsuara androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT wambiercarlosgustavo androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT vanogalvansergio androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT tostiantonella androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT shapirojerry androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT mesinkovskanatashaatanaskova androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT ramospaulomuller androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT sinclairrodney androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT lupiomar androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT hercogovajana androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster AT mccoyjohn androgeneticalopeciamaybeassociatedwithweakercovid19tcellimmuneresponseaninsightintoapotentialcovid19vaccinebooster |